Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens.
Journal article
Ternette N. et al, (2018), Proteomics, 18
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.
Journal article
Li D. et al, (2017), Cancer Res, 77, 2699 - 2711
Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies.
Journal article
Li D. et al, (2017), PLoS One, 12
Therapeutic Antibodies against Intracellular Tumor Antigens.
Journal article
Trenevska I. et al, (2017), Front Immunol, 8
The European antibody network's practical guide to finding and validating suitable antibodies for research.
Journal article
Roncador G. et al, (2016), MAbs, 8, 27 - 36
The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.
Journal article
Hatano H. et al, (2015), J Immunol, 194, 1591 - 1601
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.
Journal article
Brooks SE. et al, (2015), PLoS One, 10
The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains.
Journal article
Zhang Z. et al, (2015), PLoS One, 10
MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma.
Journal article
Li G. et al, (2014), Postgrad Med J, 90, 106 - 112
A MOLECULAR BASIS FOR THE KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR3DL2 BINDING TO HLA-B27 FREE HEAVY CHAIN DIMERS
Conference paper
Hatano H. et al, (2014), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 32, 814 - 814
Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.
Journal article
Snell CE. et al, (2014), PLoS One, 9
The notch ligand JAGGED1 as a target for anti-tumor therapy.
Journal article
Li D. et al, (2014), Front Oncol, 4
Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
Conference paper
Hatano H. et al, (2013), IMMUNOLOGY, 140, 209 - 209
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.
Journal article
Masiero M. et al, (2013), Cancer Cell, 24, 229 - 241
Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor.
Journal article
Whiteman P. et al, (2013), J Biol Chem, 288, 7305 - 7312
A novel role of CD1c in regulating CD1d-mediated NKT cell recognition by competitive binding to Ig-like transcript 4.
Journal article
Li D. et al, (2012), Int Immunol, 24, 729 - 737
HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.
Journal article
Rajapaksa US. et al, (2012), Proc Natl Acad Sci U S A, 109, 13353 - 13358
HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.
Journal article
Giles J. et al, (2012), J Immunol, 188, 6184 - 6193
Identification of self-lipids presented by CD1c and CD1d proteins.
Journal article
Haig NA. et al, (2011), J Biol Chem, 286, 37692 - 37701
A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells.
Journal article
Zhang P. et al, (2009), Immunology, 128, 500 - 510